Americans shelled out an estimated $71 billion for weight-loss drugs in 2023 - that is as much as the U.S. government ...

A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...

Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast.

Cencora raised its 2025 earnings projection on strong U.S. demand for weight-loss drugs as quarterly net income jumped 71%. The drug wholesaler formerly known as AmerisourceBergen logged earnings of ...

For this reason, microdosing these weight-loss medications isn't approved by the US Food and Drug Administration (FDA) or by other health authorities. But that hasn't stopped people from trying it ...

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

Investors are betting that Lilly will maintain its momentum. Its share price has climbed by a third since the start of 2024; ...

Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...

It might also increase heart rate and blood pressure ... Due to drug shortages and demand for weight loss medications, it’s important to get medications from reputable sources prescribed ...

Healthify is banking on the rise of GLP-1 weight-loss drugs in India, integrating them with lifestyle coaching. The firm ...

The state’s largest commercial health insurer will stop covering a popular class of prescription drugs for weight loss, ...

Schneider) WeightWatchers is planning to file for bankruptcy after failing to compete against the rise ... weight loss tools, reports have said. The business has struggled to stay relevant after ...